1. Introduction {#sec1-pathogens-08-00013}
===============

Papillomaviruses contain a double-stranded circular DNA genome of approximately 8 kb that is surrounded by a shell of viral proteins. The family *Papillomaviridae* harbors about 130 species, divided into the subfamilies *Firstpapillomavirinae* (52 genera) and *Secondpapillomavirinae* (one genus) \[[@B1-pathogens-08-00013]\]. The viruses are mainly transmitted via the sexual route or direct skin-to-skin-contact and infect basal cells in the squamous epithelium of mucosal surfaces and skin \[[@B2-pathogens-08-00013]\]. Infection of skin and anogenital mucosa with low risk human papillomaviruses (HPV), including HPV-6 and HPV-11, may result in the development of benign lesions. In contrast, infection with high risk HPV, including HPV-16 and HPV-18, is associated with a significantly elevated risk for malignant lesions, including cervix carcinoma \[[@B2-pathogens-08-00013]\].

Apart from anogenital mucosa, HPV can also infect the oral mucosa and infection might be associated with potentially malignant disorders, including oral leukoplakia, oral erythroplakia, oral proliferative verrucous leukoplakia, oral submucous fibrosis, oral lichen planus, and actinic cheilitis \[[@B3-pathogens-08-00013]\]. Moreover, oral HPV infection can cause benign lesions, including squamous cell papilloma, condyloma acuminatum, verruca vulgaris, and focal epithelial hyperplasia (FEH, also termed Heck's disease) \[[@B3-pathogens-08-00013]\]. FEH has mainly been observed among children and adolescents of American Indian origin \[[@B4-pathogens-08-00013],[@B5-pathogens-08-00013]\] and in Inuit \[[@B6-pathogens-08-00013],[@B7-pathogens-08-00013]\], but has occasionally also been detected in other populations. Males and females are equally affected by FEH and genetic predisposition seems to impact susceptibility to disease \[[@B3-pathogens-08-00013],[@B8-pathogens-08-00013],[@B9-pathogens-08-00013]\]. FEH lesions are round or ovoid, can heal spontaneously and are most frequently observed in the labial and buccal mucosa \[[@B3-pathogens-08-00013],[@B10-pathogens-08-00013]\]. Finally, HPV-13 and HPV-32 infections were found to be associated with FEH \[[@B11-pathogens-08-00013],[@B12-pathogens-08-00013]\].

An outbreak of FEH in a colony of bonobos (pygmy chimpanzees, *Pan paniscus*) was observed in a zoological garden in 1987 and was found to be associated with an HPV13-related virus, Pan paniscus Papillomavirus 1 (PpPV1, <https://pave.niaid.nih.gov/>; previously termed pygmy chimpanzee papillomavirus 1) \[[@B13-pathogens-08-00013],[@B14-pathogens-08-00013]\]. PpPV1 and HPV-13 share 85% similarity at the nucleotide level and display an identical genome organization \[[@B13-pathogens-08-00013]\]. Several aspects of PpPV1 infection and PpPV1-induced FEH are poorly understood. Thus, when FEH went into partial (two out of five animals) or complete remission (three out of five animals) in the afflicted bonobos after the first detection of lesions in 1987, it remained unknown whether the animals with partial remission ultimately became disease free \[[@B13-pathogens-08-00013],[@B14-pathogens-08-00013]\]. Moreover, PpPV1 sequence diversity has not been investigated. We obtained a sample from a bonobo with FEH (as determined by gross examination) that was submitted for virus diagnostics and analysis of the donors records revealed that it was part of the bonobo colony in which PpPV1 had initially been identified in the late 1980s \[[@B14-pathogens-08-00013]\]. This afforded the opportunity to investigate whether viral infection was still active and whether disease manifestation and viral genome sequence had changed over a period of almost 30 years.

Here, we report that the animal suffered from FEH, suggesting that either the disease did not undergo full remission or recurred, and that viral antigens were detectable in the oral mucosa, demonstrating active viral infection. Moreover, we show that the viral genome sequence had a total of 23 nucleotide exchanges, 11 of which resulted in amino acid changes compared to the reference genome that was obtained from the initial outbreak in 1987 \[[@B14-pathogens-08-00013]\].

2. Materials and Methods {#sec2-pathogens-08-00013}
========================

2.1. Sample Acquisition {#sec2dot1-pathogens-08-00013}
-----------------------

On 30 November 2017, tissue samples from a lesion in the oral cavity of a bonobo (*Pan paniscus*) that was kept at Leipzig zoological garden, Germany, was sent to the German Primate Center for clarification of the cause for the tissue alterations. Upon arrival, the tissue sample was halved. One part was placed in 10% buffered formalin for a microscopic examination and the other part was used for PCR (polymerase chain reaction) examination.

Samples from a bonobo housed in a zoological garden for public display were analyzed in the present study. Institutional policies of the zoological garden require that animal health is monitored daily. Monitoring revealed that the bonobo had difficulties with ingestion. In order to determine the underlying reasons, the oral cavity was examined. Samples were taken from the anesthetized animal by certified veterinarians and then subjected to diagnostic tests for viral infections. Approval by an ethics committee or institutional review board was not required.

2.2. Histological and Immunohistochemical Examinations {#sec2dot2-pathogens-08-00013}
------------------------------------------------------

Formalin-fixed biopsy samples of the oral lesion were dehydrated, embedded in paraffin wax, cut into 4 µm sections, and processed for histopathology and immunohistochemistry. The histopathological examination was performed on haemalaun and eosin (H&E) stained sections. For immunohistochemistry, a mouse monoclonal antibody crossreactive against various HPV, including HPV-13, was employed as primary antibody (LifeSpan BioSciences, Seattle, WA, USA). The immunostaining was performed with the peroxidase-antiperoxidase (PAP) method and 3.3´-diaminobenzidine tetrahydrochloride (DAB) as a chromogen \[[@B15-pathogens-08-00013]\]. In detail, tissue sections were dewaxed, rehydrated, and incubated with 3% H~2~O~2~ in methanol for 30 minutes (min) at room temperature (RT) to block the endogenous peroxidase activity. The primary antibody (1:150) was incubated overnight at 4 °C. This was followed by several washing steps and the application of rat anti-mouse immunoglobulin as a bridge antibody (1:100, Dianova, Hamburg, Germany, 30 min, RT). Sections were thoroughly rinsed, treated with mouse-PAP-complex (1:500, Dianova) for 30 min at RT, washed again, and incubated in DAB (10 min). Sections were counterstained with Papanicolaou's solution.

In the negative control, the primary antibody was replaced with a non-binding isotype-matched control antibody.

The antibodies and the PAP-complex were diluted with tris-buffered saline (TBS) containing 1% bovine serum albumin (BSA). For all washing steps, TBS was used.

2.3. PCR-Based Detection of PpPV1 {#sec2dot3-pathogens-08-00013}
---------------------------------

Total DNA of unfixed tissue (≈50 mg tissue) was extracted by means of a First-DNA All-Tissue Kit (GEN-IAL GmbH, Troisdorf, Germany) as recommended by the manufacturer (elution volume, 100 µL). Next, the extracted DNA was quantified using a NanoDrop ND-1000 spectrophotometer (Peqlab, Erlangen, Germany) and further subjected to a PCR protocol that detects a broad range of papillomaviruses. The PCR-mix was prepared on ice and consisted of the following components: 100 ng extracted DNA, 1.2 µM forward primer (FAP64, 5′-CCWATATCWVHCATITCICCATC-3′) \[[@B16-pathogens-08-00013]\], 1.2 µM reverse primer (FAP6085, 5′-CCWGATCCHAATMRRTTTGC-3′) \[[@B17-pathogens-08-00013]\], 200 µM dNTPs (each), 2 mM magnesium chloride, 5% DMSO (dimethyl sulfoxide), 2.5 µL 10× reaction buffer, and 1.25 U HotStar Taq DNA Polymerase (QIAGEN, Hilden, Germany). DEPC (diethyl pyrocarbonate)-treated water was used for equilibration to a total volume of 25 µL and the PCR was subsequently performed under the following conditions (a reaction that contained water instead of DNA was used as a negative control): one cycle at 95 °C for 4 min, 30 sec; 55 cycles consisting of 95 °C for 20 sec, 46 °C for 30 sec, and 72 °C for 30 sec; and one cycle at 72 °C for 10 min. Reactions were then mixed with 5 µL of 6× Purple Loading Dye (New England Biolabs, Ipswich, MA, USA), and subjected to agarose gel electrophoresis using a 1.5% agarose gel containing 1 µg/mL ethidium bromide. After that, the gel was imaged under UV light and a band of the expected size (≈380 bp) present in the analyzed sample was excised from the gel, purified using the NucleoSpin Gel and PCR Clean-up kit according to manufacturer's protocol (Macherey-Nagel, Düren, Germany) and send to a commercial sequencing service (Microsynth SeqLab, Göttingen, Germany) for Sanger sequencing using the primers used for amplification. The resulting sequences were assessed for quality by inspecting the chromatograms. Further, the resulting sequences were analyzed using the basic local alignment search tool for nucleotide sequences (BLASTn; National Center for Biotechnology Information, Bethesda, MD, USA) and revealed 100% sequence identity to X62844.1 (Pygmy Chimpanzee papilloma virus type 1 DNA, now termed Pan paniscus Papillomavirus 1) after the removal of primer-specific sequences.

2.4. Amplification and Sequencing of DNA Fragments Covering the Whole PpPV1 Genome {#sec2dot4-pathogens-08-00013}
----------------------------------------------------------------------------------

After confirmation that the sample was positive for PpPV1, we designed primers for PCR amplification of overlapping fragments of the published genome found under the GenBank entry X62844.1 ([Table 1](#pathogens-08-00013-t001){ref-type="table"}). All reactions were prepared on ice and consisted of the following components: 100 ng extracted DNA, 1 µM forward primer, 1 µM reverse primer, 200 µM dNTPs (each), 5% DMSO, 5 µL 5× HF buffer and 1 U Phusion High-Fidelity Polymerase (Thermo Fisher Scientific, Waltham, MA, USA). DEPC-treated water was used for equilibration to a total volume of 25 µL and the PCR was subsequently performed under the following conditions: one cycle at 96 °C for 2 min; 35 cycles consisting of 96 °C for 30 sec, 54 °C for 30 sec, and 72 °C for 90 sec; and one cycle at 72 °C for 10 min. Reactions were then mixed with 5 µL of 6× Purple Loading Dye (New England Biolabs), and subjected to agarose gel electrophoresis using a 1.0% agarose gel containing 1 µg/mL ethidium bromide. After that, the gel was imaged under UV light, and the obtained bands were excised from the gel, purified, and sent for sequencing.

To minimize the risk of sequence errors resulting from false nucleotide incorporations by the polymerase during PCR, we utilized a polymerase with proof-reading activity and each nucleotide of the PpPV1 genome was covered by at least two individual PCRs (fragments are summarized in [Table 2](#pathogens-08-00013-t002){ref-type="table"}). Further, we verified every single nucleotide of the PpPV1 genome by sequencing reactions based on at least two individual amplicons and sequenced both the + and the − strand.

The full PpPV1 genome was assembled from the individual sequencing reads and aligned to the published reference genome (X62844.1) using MEGA6 (<https://www.megasoftware.net/>) \[[@B18-pathogens-08-00013]\]. The obtained PpPV1 genome has been submitted to GenBank and can be accessed via the accession number MK303593.

3. Results {#sec3-pathogens-08-00013}
==========

The animal, a 36-year-old male bonobo born in a zoological garden in Antwerp \[[@B13-pathogens-08-00013],[@B14-pathogens-08-00013]\], was immobilized due to difficulties with ingestion. Visual inspection of the oral cavity revealed two broken incisors as well as lesions. The lesions had a cauliflower-like and nodular shape and were detected on the interior lip, vestibules, and gingivae but not on tongue and soft and hard palate ([Figure 1](#pathogens-08-00013-f001){ref-type="fig"}a). Histopathological examination revealed multifocal areas of marked irregular epithelial hyperplasia (acanthosis) with distinct rete ridges and the presence of numerous koilocytes in superficial epithelial cell layers. The latter represent keratinocytes with a prominent cytoplasmic vacuolation ([Figure 1](#pathogens-08-00013-f001){ref-type="fig"}b). Rarely, degeneration of individual epithelial cells was observed. The stratum corneum showed mild to moderate parakeratosis. A mild infiltration with lymphocytes, plasma cells, and neutrophils was present in the epithelium and underlying fibrovascular connective tissue. Numerous keratinocytes, including koilocytes of the stratum spinosum, showed a positive nuclear immunostaining for the PV antigen ([Figure 1](#pathogens-08-00013-f001){ref-type="fig"}c). Finally, PCR with FAP64 and FAP6085 primers specific for a region in the L1 gene of papillomaviruses \[[@B16-pathogens-08-00013],[@B17-pathogens-08-00013]\] amplified a ≈380 bp fragment expected for HPV genome ([Figure 1](#pathogens-08-00013-f001){ref-type="fig"}d), and Sanger sequencing in combination with sequence analysis confirmed that the sequence was identical to that previously published for PpPV1 (not shown). In sum, our results confirmed a PpPV1 infection and show that FEH did only partially regress after its first diagnosis in 1987.

At present, sequence evolution and diversity of PpPV1 are largely unknown. Therefore, we sought to compare the viral genomic sequences present at the time of first diagnosis in the late 1980s and detected within the present study. For this, we PCR-amplified a total of 18 overlapping fragments spanning the entire viral genome and determined the sequences of the complete + and − strand. Sequence analysis showed that genomic sequences identified in the present study and those deposited in GenBank in 1991 (X62844.1, the original sequence has been updated in 2005) differed in 23 nucleotides, resulting in a sequence identity of 99.71% ([Figure 2](#pathogens-08-00013-f002){ref-type="fig"} and [Table 3](#pathogens-08-00013-t003){ref-type="table"}). Three mutations were located in the non-translated region located at the 3' end of the L1 open reading frame. In contrast, 20 changes were found in coding regions, and of those 11 resulted in a change in the amino acid sequence ([Table 3](#pathogens-08-00013-t003){ref-type="table"}). The highest number of amino acid changes was observed in the L2 protein (n = 3), while two changes were detected in both the E1 and L1 protein. Finally, single amino acid changes were detected in the E5ɣ and E7 proteins ([Table 3](#pathogens-08-00013-t003){ref-type="table"}).

4. Discussion {#sec4-pathogens-08-00013}
=============

Infection of the oral mucosa by HPV and its consequences are incompletely understood, although detection of high risk HPV in buccal mucosa has been reported and infection by HPV-13 and HPV-32 has been shown to be associated with FEH \[[@B11-pathogens-08-00013],[@B12-pathogens-08-00013],[@B19-pathogens-08-00013],[@B20-pathogens-08-00013]\]. Here, we report continued FEH in a bonobo that has been first diagnosed with the diseases in 1987 and reported the genomic sequence of the causative agent, PpPV1.

The animal investigated in the present study, a 36-year-old bonobo named Joey, was first diagnosed with FEH in 1987 \[[@B14-pathogens-08-00013]\]. At this time, Joey was part of colony of eight bonobos that were born in different places (Kinshasa, Stuttgart, and Antwerp) and that were co-housed in a zoological garden in Antwerp. Five out of the eight animals were diagnosed with FEH in 1987, while three were disease free \[[@B14-pathogens-08-00013]\]. Within the next approximately three to four years, three out of the five animals with FEH became disease free \[[@B14-pathogens-08-00013]\], in keeping with the observation that FEH due to HPV-13 infection can undergo complete remission in human patients \[[@B3-pathogens-08-00013],[@B10-pathogens-08-00013]\]. In contrast, Joey and another animal showed incomplete remission approximately four years after FEH diagnosis \[[@B14-pathogens-08-00013]\]. In keeping with the incomplete remission of FEH in Joey, we observed no lesions on tongue and hard palate, although these areas contained lesions in 1987. However, it is unknown whether lesions remained constant over decades or recurred after periods of complete remission. Finally, it should be stated that the bonobo colony in Antwerp has not been subject to follow-up studies, although FEH was reported in an animal imported from Antwerp to San Diego \[[@B21-pathogens-08-00013]\], and that Joey is currently co-housed with 11 bonobos, of which the FEH status is unknown.

The detection of viral proteins in lesions suggested persistent infection and the PpPV1 genome could be readily PCR amplified from buccal mucosa samples. This allowed us to determine its sequence. The PpPV1 sequence obtained differed in 23 nucleotides from the sequence reported in 1992 \[[@B13-pathogens-08-00013]\] and 11 of the 23 changes resulted in amino acid substitutions in viral proteins. The lack of adequate cell lines and functional assays precluded testing whether these changes altered virus--host cell interactions. Moreover, the reasons for the notable sequence differences could not be elucidated. However, we can offer several speculations. First, the differences in the present PpPV1 sequence and the sequence reported in 1992 might reflect inter-host diversity, which can be substantial for papillomaviruses \[[@B22-pathogens-08-00013],[@B23-pathogens-08-00013]\]. Thus, it has not been documented whether the PpPV1 sequence reported in 1992 was obtained from material from Joey or another infected bonobo from the same colony and it cannot be excluded that the FEH outbreak observed in the bonobo colony in 1987 was due to two or more parallel introductions of PpPV1 from different sources. Moreover, it is conceivable that Joey was infected with a different PpPV1 variant after the FEH was epizootic in the colony in Antwerp, since co-infection with different papillomavirus types can occur despite mechanisms preventing superinfection being operative in infected cells \[[@B24-pathogens-08-00013]\]. Second, the sequence differences might be due to intra-host evolution. This scenario seems unlikely, since the papillomavirus evolutionary rate is believed to be too low to allow analysis via viral passaging in cell culture or via studying sequential samples taken from an infected host \[[@B25-pathogens-08-00013],[@B26-pathogens-08-00013],[@B27-pathogens-08-00013]\]. However, we note that recent studies suggest substantial intra-host diversity of HPV at given time points after infection \[[@B28-pathogens-08-00013],[@B29-pathogens-08-00013]\]. Moreover, consecutive samples from Joey are not available but would be required to demonstrate sequence evolution. Third, it cannot be excluded that a fraction of the nucleotide changes observed might be due to PCR errors, as sequencing technology has improved since the time when the initial study was performed. With respect to this, we would like to point out that in the present study, both the + and the -- strand were sequenced and an enzyme with proof-reading activity was used for PCR amplification of PpPV1 sequences.

5. Conclusions {#sec5-pathogens-08-00013}
==============

Our study indicates that FEH induced by PpPV1 might not undergo remission in some animals and provides insights into PpPV1 sequence diversity or evolution.
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![Focal epithelial hyperplasia and papillomavirus infection in the oral cavity. (**a**) Macroscopic findings of focal epithelial hyperplasia in the oral cavity. (**b**) Histological features of focal epithelial hyperplasia: There is marked irregular epithelial hyperplasia with formation of distinct rete ridges. The pallor of the superficial layers (asterisk) is caused by the presence of numerous koilocytes. Bar, 200 µm. Inset: Koilocytes that are characterized by cytoplasmic vacuolation are depicted at a higher magnification. Bar, 20 µm. Haemalaun & eosin stain. (**c**) Immunostaining for papillomavirus antigen: several keratinocytes of the stratum spinosum including koilocytes contained immunopositive nuclei (arrows). Bar, 50 µm. (**d**) PCR-based papillomavirus detection in the tissue sample from the oral cavity of the bonobo. Lane 1, DNA ladder (GeneRuler DNA Ladder Mix, Thermo Fisher Scientific); lane 2, negative control (water was used instead of DNA for PCR); lane 3, DNA from tissue sample. The arrowhead indicates the positive band at ≈380 bp. Small numbers on the left side indicate the size of selected reference bands of the DNA ladder (given as base pairs, bp).](pathogens-08-00013-g001){#pathogens-08-00013-f001}

![Schematic representation of the Pan paniscus Papillomavirus 1 (PpPV1) genome and location of the identified nucleotide variations. PpPV1 contains a circular, double-stranded DNA genome of 7902 bp that codes for a total of eleven proteins from different transcriptional frames (for simplicity, the circular genome is shown in a linearized fashion). Nucleotide differences in comparison to the original sequence (X62844.1) are highlighted between the schematic genome and the scale. Black stars indicate nucleotide differences that led to amino acid changes in open reading frames (ORFs) of the genome, while grey and white stars refer to nucleotide differences that do not translate into amino acid changes and that were located in non-translated regions, respectively. kbp, kilobase pairs.](pathogens-08-00013-g002){#pathogens-08-00013-f002}

pathogens-08-00013-t001_Table 1

###### 

Primers designed for amplification of fragments covering the Pan paniscus Papillomavirus 1 (PpPV1) genome.

  Name       Sequence (5′--3′)
  ---------- ------------------------
  PpPV1_1F   CAGCTCAGAAGAAGATGAGG
  PpPV1_1R   CTTAGTAATACTAACAATAGC
  PpPV1_2F   TGCATCATAGTGTGTCTGAGG
  PpPV1_2R   TTCTGTCAAAAGGGAATGG
  PpPV1_3F   TAGAAAACATAAATCGTTAGC
  PpPV1_3R   CCTGTGCAAGGGTGGTTGTGG
  PpPV1_4F   AGCAAAGTTATATGTTCTCC
  PpPV1_4R   CTGCGAGGCCTACTATGTGC
  PpPV1_5F   TTACTGCATATTAGAACTGG
  PpPV1_5R   CGTCCACCAATATGTTTGCC
  PpPV1_6F   GGCTATAACGTCTAGGCGTGG
  PpPV1_6R   ACACCTGAACATTGTGTGCC
  PpPV1_7F   GTTTGGTGTGGGCCTGTATAGG
  PpPV1_7R   AAACTGAGACCTGCATAAGG
  PpPV1_8F   TTTAGAAGAATGGAACTTTGG
  PpPV1_8R   GAAACCGTTTTCGGTCCCTCC
  PpPV1_9F   AATCCTTTTTGGCTACCAGC
  PpPV1_9R   ATGTCCGATCCTGTACAGTCC

pathogens-08-00013-t002_Table 2

###### 

Amplicons produced to cover the Pan paniscus Papillomavirus 1 (PpPV1) genome.

  Primer For   Primer Rev   Amplicon   Amplicon Size (bp)   Genome Region (nt)
  ------------ ------------ ---------- -------------------- --------------------
  PpPV1_1F     PpPV1_1R     1a         1055                 618--1672
  PpPV1_2R     1b           2005       618--2622            
  PpPV1_2F     PpPV1_2R     2a         1062                 1561--2622
  PpPV1_3R     2b           1825       1561--3385           
  PpPV1_3F     PpPV1_3R     3a         909                  2477--3385
  PpPV1_4R     3b           1914       2477--4390           
  PpPV1_4F     PpPV1_4R     4a         1102                 3289--4390
  PpPV1_5R     4b           2038       3289--5326           
  PpPV1_5F     PpPV1_5R     5a         1046                 4281--5326
  PpPV1_6R     5b           1989       4281--6269           
  PpPV1_6F     PpPV1_6R     6a         1036                 5234--6269
  PpPV1_7R     6b           1843       5234--7076           
  PpPV1_7F     PpPV1_7R     7a         1051                 6026--7076
  PpPV1_8R     7b           1927       6026--50             
  PpPV1_8F     PpPV1_8R     8a         1020                 6933--50
  PpPV1_9R     8b           1728       6933--758            
  PpPV1_9F     PpPV1_9R     9a         912                  7749--758
  PpPV1_1R     9b           1826       7749--1672           

pathogens-08-00013-t003_Table 3

###### 

Summary of the identified nucleotide variations and their effect on protein level.

  Genome     Genetic Element   Open Reading Frame                              
  ---------- ----------------- -------------------- ------ ------ ------------ ------
  711        G711C             E7                   180    60     Q60H         CAx
  861        A861G             E1                   28     10     K10E         xAG
  1170       A1170C            E1                   337    113    I113L        xTA
  1964       T1964C            E1                   1131   377    silent (F)   TTx
  2172       A2172C            E1                   1339   447    silent (R)   xGG
  3472 ^d^   C3472G            E2                   751    251    R251G        xGA
  3666 ^e^   C3666A            E2                   945    315    D315E        GAx
  3472 ^d^   C3472G            E4                   189    63     silent (L)   CTx
  3472 ^d^   C3472G            E1\^E4               165    55     silent (L)   CTx
  3666 ^e^   C3472G            E8\^E2               187    63     R187G        xGA
  3472 ^d^   C3666A            E8\^E2               381    127    D381E        GAx
  4136       G4136C            E5ɣ                  237    79     L79F         TTx
  4883       C4883A            L2                   516    172    silent (P)   CCx
  5217       G5217A            L2                   850    284    V284I        xTA
  5477       G5477A            L2                   1110   370    silent (S)   TCx
  5523       A5523C            L2                   1156   386    K386Q        xAG
  5613       G5613A            L2                   1246   416    C416Y        TxT
  5900       G5900A            L1                   155    52     R52K         AxA
  6543       G6543A            L1                   798    266    silent (E)   GAx
  6549       A6549T            L1                   804    268    silent (I)   ATx
  6555       A6555C            L1                   810    270    E270D        GAx
  6573       G6573T            L1                   828    276    silent (G)   GGx
  7071       C7071T            L1                   1326   442    silent (L)   CTx
  7089       T7089C            L1                   1344   448    silent (N)   AAx
  7443       G7443C            URR                  n.a.   n.a.   n.a.         n.a.
  7469       A7469C            URR                  n.a.   n.a.   n.a.         n.a.
  7726       C7726G            URR                  n.a.   n.a.   n.a.         n.a.

a: Nucleotide difference compared to the reference sequence (X62844.1); b: Effect of the nucleotide variation on protein level (for silent mutations, the letters written in brackets indicate the respective amino acid residue); c: The affected nucleotide is indicated by the letter "x"; d: Identical genome position (the coding region for E2, E4, E1\^E4, and E8\^E2 partially overlap); e: Identical genome position (the coding region for E2 and E8\^E2 partially overlap); Abbreviations: nt = nucleotide, aa = amino acid residue, URR = upstream regulatory region, n.a. = not applicable.
